Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
- PMID: 27567467
- DOI: 10.1016/S2215-0366(16)30188-2
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
Abstract
Background: Although cannabis use after a first episode of psychosis has been associated with relapse, little is known about the determinants of this most preventable risk factor for relapse of psychosis. Here we aimed to study whether the effects on outcome vary depending on the type of cannabis consumed and usage pattern.
Methods: In this observational study, we prospectively recruited and followed up patients aged 18-65 years who presented with their first episode of psychosis to psychiatric services in south London, London, UK. Relapse of psychosis within 2 years after onset of psychosis was defined as risk of subsequent admission to hospital. We classified patients into different patterns of cannabis use based on continuity of use after onset of psychosis, potency of cannabis consumed, and frequency of use after the onset of their illness. We used multiple regression analyses (logistic or binominal) to compare the different cannabis use groups and propensity score analysis to validate the results.
Findings: Between April 12, 2002, and July 26, 2013, 256 patients presented with a first episode of psychosis. We did follow-up assessments for these patients until September, 2015. Simple analyses showed that former regular users of cannabis who stopped after the onset of psychosis had the most favourable illness course with regards to relapse. In multiple analysis, continued high-frequency users (ie, daily use in all 24 months) of high-potency (skunk-like) cannabis had the worst outcome, indexed as an increased risk for a subsequent relapse (odds ratio [OR] 3·28; 95% CI 1·22-9·18), more relapses (incidence rate ratio 1·77; 95% CI 0·96-3·25), fewer months until a relapse occurred (b -0·22; 95% CI -0·40 to -0·04), and more intense psychiatric care (OR 3·16; 95% CI 1·26-8·09) after the onset of psychosis.
Interpretation: Adverse effects associated with continued use of cannabis after the onset of a first episode of psychosis depend on the specific patterns of use. Possible interventions could focus on persuading cannabis-using patients with psychosis to reduce use or shift to less potent forms of cannabis.
Funding: National Institute for Health Research (NIHR).
Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.
Comment in
-
Cannabis and psychosis: understanding the smoke signals.Lancet Psychiatry. 2016 Oct;3(10):909-910. doi: 10.1016/S2215-0366(16)30230-9. Epub 2016 Aug 23. Lancet Psychiatry. 2016. PMID: 27567466 No abstract available.
-
Daily use of high-potency cannabis is associated with an increased risk of admission and more intervention after first-episode psychosis.Evid Based Ment Health. 2017 May;20(2):58. doi: 10.1136/eb-2017-102630. Epub 2017 Mar 23. Evid Based Ment Health. 2017. PMID: 28341798 Free PMC article. No abstract available.
Similar articles
-
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.Lancet Psychiatry. 2017 Aug;4(8):627-633. doi: 10.1016/S2215-0366(17)30233-X. Epub 2017 Jul 10. Lancet Psychiatry. 2017. PMID: 28705600 Free PMC article.
-
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.Lancet Psychiatry. 2015 Mar;2(3):233-8. doi: 10.1016/S2215-0366(14)00117-5. Epub 2015 Feb 25. Lancet Psychiatry. 2015. PMID: 26359901
-
Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.JAMA Psychiatry. 2016 Nov 1;73(11):1173-1179. doi: 10.1001/jamapsychiatry.2016.2427. JAMA Psychiatry. 2016. PMID: 27680429
-
Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.Aust N Z J Psychiatry. 2016 Mar;50(3):208-19. doi: 10.1177/0004867415599846. Epub 2015 Aug 18. Aust N Z J Psychiatry. 2016. PMID: 26286531 Review.
-
Cannabis as a risk factor for psychosis: systematic review.J Psychopharmacol. 2005 Mar;19(2):187-94. doi: 10.1177/0269881105049040. J Psychopharmacol. 2005. PMID: 15871146
Cited by
-
Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale.Can J Psychiatry. 2024 Jul;69(7):524-535. doi: 10.1177/07067437241242395. Epub 2024 Apr 4. Can J Psychiatry. 2024. PMID: 38571478 Free PMC article.
-
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.Lancet Psychiatry. 2017 Aug;4(8):627-633. doi: 10.1016/S2215-0366(17)30233-X. Epub 2017 Jul 10. Lancet Psychiatry. 2017. PMID: 28705600 Free PMC article.
-
Trends and characteristics of cannabis-associated emergency department visits in the United States, 2006-2018.Drug Alcohol Depend. 2022 Mar 1;232:109288. doi: 10.1016/j.drugalcdep.2022.109288. Epub 2022 Jan 10. Drug Alcohol Depend. 2022. PMID: 35033959 Free PMC article.
-
The effects of cannabis use on salience attribution: a systematic review.Acta Neuropsychiatr. 2018 Feb;30(1):43-57. doi: 10.1017/neu.2016.58. Epub 2016 Nov 21. Acta Neuropsychiatr. 2018. PMID: 27866486 Free PMC article.
-
Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial.JMIR Res Protoc. 2023 Dec 18;12:e53094. doi: 10.2196/53094. JMIR Res Protoc. 2023. PMID: 38109196 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous